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Mutations in cardiac troponin T (TnT) associated with hypertrophic cardiomy-
opathy (HCM) generally lead to an increase in the calcium (Ca) sensitivity of
contraction. In contrast, TnT mutations linked to dilated cardiomyopathy
(DCM) decrease the Ca sensitivity of contraction.Here we test the hypothesis
that two TnT disease mutations with opposite effects on the myofilament Ca
sensitivity can rescue each other. To test this hypothesis, we crossed transgenic
mice expressing the HCM TnT-I79N mutation with a DCM knock-in (KI)
mouse model carrying the TnT-R141W mutation. Two double-transgenic ani-
mals were studied: I79N/R141Wmut/þ and I79N/R141Wmut/mut which con-
tained the HCM TnT-I79N transgene and either one or two alleles carrying
the DCMTnT-R141Wmutation, respectively. The Ca sensitivity of contraction
was measured in skinned cardiac muscle fibers and compared to WT, I79N TG
and heterozygous R141Wmut/þ KI mice hearts.The results of the Ca sensitivity
ranked from highest to lowest were as follow: I79N > I79N/R141Wmut/þ >
I79N/R141Wmut/mut > WT > R141Wmut/þ. In vivo testing showed that the dou-
ble transgenic mice had reduced arrhythmia susceptibility and tissue fibrosis
compared to I79N TG mice, a hallmark of HCM. Furthermore, the double
transgenic mice had reduced heart/body weight ratio compared to mice car-
rying only the DCM TnT-R141W mutations. These results suggest that car-
rying two disease mutations in TnT that have opposite effects on the
myofilament Ca sensitivity can paradoxically rescue the disease phenotype.
The data further point towards an independent role of changes in the Ca sensi-
tivity in the pathogenesis of DCM and HCM. Future studies will explore the in
vivo cardiac function of the double-transgenic mice.
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Introduction: Many of cTnT mutations linked to cardiomyopathies fall the
TNT1 domain/N terminal tail region of unresolved high definition structure.
This region (~94-170) of cTnT is critical to Tm binding and contraction regu-
lation. Here, the impact of the E163R mutation in cTnT-TNT1 on contractile
function and tension cost was investigated using intact and skinned prepara-
tions from WT and transgenic mouse hearts.
Methods: Left and right ventricular trabeculae were dissected from non-
transgenic wild type (WT) and heterozygous (D160E or E163R) mouse hearts
and mounted isometrically to record twitch tension or, when skinned, Ca2þ
activated force. Myofibrillar ATPase activity was measured by fluorimetric
enzyme coupled assay (de Tombe and Stienen, 1995).
Results: Myocardium of E163R mice shows: (i) no change of myosin isoform
expression (ii) maintained peak isomentric twitch tension at all stimulation fre-
quencies, (iii) prolonged time to peak and time to 50% relaxation, with pre-
served rate-adaptation of twitch duration, (iv) changes of the short-term
interval force relationship and increased occurrence of spontaneous contrac-
tions. No significant differences were found in maximum Ca2þ activated ten-
sion of E163R and WT skinned trabeculae. However, Ca2þ sensitivity of
tension was significantly increased in E163R skinned trabeculae when
compared with WT. As to the economy of force maintenance, preliminary ex-
periments suggest an increase of tension cost in trabeculae from E163R hearts.
Resting ATPase activity also tended to be higher in E163R preparations. Ki-
netics of force development and relaxation will be assessed on single myofi-
brils, isolated from the same hearts.
Conclusions: Both primary sarcomeric changes and secondary E-C coupling al-
terations contribute to mechanical impairment in E163R cTnT mutant myocar-
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Impaired systolic function resulting from acute injury, congenital defect, or
aging can lead to cardiac complications and heart failure. Current therapies
are unable to rescue cardiac function, but merely slow disease progression.
We have demonstrated that when myosin uses 2-deoxy-ATP (dATP) as an
energy substrate for contraction instead of ATP, cardiac contractility is
enhanced by 20% or more. Viral-vector mediated overexpression of R1R2,
the enzyme that catalyzes production of deoxy-nucleotides, increases intra-
cellular dATP. In this study we determined the expression pattern of R1R2
in mice following systemic delivery of recombinant adeno-associated viral
vectors pseudotyped with the type 6 capsid (rAAV6) carrying R1 and R2
subunits, and a cardiac specific gene regulatory cassette (cTnT455). Cardiac
function was assessed in vivo via echocardiography, and ex vivo using Lan-
gendorf perfusion to test the hypothesis that elevating myocardial dATP by a
gene therapy approach enhances cardiac function. We also performed metab-
olomics evaluation of both skeletal and cardiac muscle to correlate with
changes in cardiac function. Our current data suggest that systemic delivery
of this rAAV6 system results in myocardial specific overexpression of R1R2
and improves basal cardiac performance, which supports our previously pub-
lished data for transgenic animals with long-term overexpression of R1R2.
Metabolic analysis suggests that R1R2 overexpression in the heart alone al-
ters the glucose metabolism of both skeletal and cardiac muscle, indicating
improved basal cardiac performance can directly impact skeletal muscle
metabolism. Preliminary studies in an aging model demonstrate that treat-
ment with this rAAV6 vector increases oxidative metabolism in cardiac
tissue and increases glycolysis in fast twitch skeletal muscle. These data
indicate that vector-mediated overexpression of R1R2 improves basal
cardiac function and impacts skeletal muscle metabolism, demonstrating po-
tential to improve cardiac function of patients with systolic dysfunction.
HL11197.
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The giant sarcomeric protein titin spans the length of the half sarcomere and
consists of an I-band region that functions as a molecular spring and a less
well understood A-band region. Here we characterize a mouse model in
which a portion of titin near the A-I junction has been removed(AIKO).
We measured passive stiffness using a muscle mechanics stretch-hold-
release protocol in which a skinned fiber from the left ventricle papillary
was stretched to a given sarcomere length(SL) within the physiological range,
held for 90 seconds, and subjected to a sinusoidal frequency sweep. Active
tensions were measured at SL=2.0mm and SL=2.2mm in both tissue types.
We found that both total and titin-based passive stiffness was significantly
higher in the AI KO compared to WT; at SL=2.3mm peak total passive ten-
sion was 43.5þ/8.3mN/mm2 in the KO compared to 23.5þ/-3.6mN/mm2 in
the WT while peak titin-based passive tension was 28.7þ/-7.0mN/mm2 in
the AI KO compared to 13.8þ/-2.0mN/mm2 in the WT. A similar trend
was observed for total and titin-based steady state passive tensions. No sig-
nificant differences in active tensions were observed at either SL indicating
no major changes to the thick filament or myofilament area; this suggests
the passive tension difference is intrinsic to titin. The sinusoidal frequency
sweep was used to quantify the vicious and elastic modulus. Viscous and
elastic moduli are defined as (s/ε)sin(q) and (s/ε)cos(q) respectively where
